Cannabis
November 7, 2017 | |
Marc Ullman was interviewed for an article in Natural Products Insider entitled, “Hemp Lawyer: FDA CBD Warning Letters Shouldn’t Alarm Industry.” The article centers on the FDA’s intolerance of claims that CBD-containing foods and dietary supplements treat diseases such as cancer. The FDA advised that CBD (cannabidiol) cannot be sold in dietary supplements, or added to
Read MoreOctober 19, 2016 | | |
Marc Ullman was quoted in a recent Nutritional Outlook article entitled, “Will Hemp CBD’s Regulatory Controversy Help or Hurt Its Future as a Supplement Ingredient?”
To read the full article, Click Here.
Read More- AI
- Appeals
- Banking
- Bankruptcy
- Business Dissolution
- Cannabis
- Commercial Litigation
- Complex Torts & Product Liability
- Compliance Investigations & White Collar
- Construction
- Corporate
- Directors & Officers Liability
- Diversity & Inclusion
- Elder Law
- Environment
- General Liability
- Health Services
- Insurance Coverage
- Insurance Fraud
- Intellectual Property
- Labor & Employment
- Medical Malpractice Defense
- Privacy, Data & Cyber Law
- Professional Liability
- Real Estate, Zoning & Land Use
- Tax
- Trusts & Estates